Using Nanopore Sequencing to Identify Pathogens in Eye Infections
Official title: Nanopore Sequencing in Ophthalmology - a Paradigm Shift in Pathogen Determination?
Run by Medical University of Graz · NCT05372861 · Data updated 2026-11-12
This study is testing whether a new device can quickly identify germs causing eye infections in patients undergoing surgery, to see if it works better than the usual methods.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Medical University of Graz Academic / other |
| Locations | 1 site (Graz, Styria) |
| Status | Recruiting |
| Started | April 22, 2022 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2027 |
| Registry record updated | October 20, 2026 |
| Trial ID | NCT05372861 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with endophthalmitis who are undergoing vitrectomy.
✕Probably not a fit
Patients who are unable to provide informed consent or are participating in other studies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study assesses the feasibility of using the Oxford Nanopore MinION device to identify pathogens in vitrectomy samples from patients with endophthalmitis. During routine vitrectomy, vitreous samples and anterior chamber taps are collected and split for both standard microbial culture and nanopore sequencing. The results from nanopore sequencing are then compared to traditional culture methods to evaluate their effectiveness in pathogen identification. Clinical data regarding visual function and other features are also collected to provide a comprehensive overview of patient outcomes.
Why it matters
Potential benefit: If successful, this approach could lead to faster and more accurate identification of pathogens in endophthalmitis, improving treatment outcomes for patients.
How similar studies have gone: While the use of nanopore sequencing in infectious diseases is promising, this specific application in ophthalmology is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Eyes of patients with endophthalmitis Exclusion Criteria: * No informed consent possible * Participation in other studies
Where it's running
-
Universitäts Augenklinik Graz
Graz, Styria, Austria Recruiting
Study contacts
- Study coordinator: Michael Sommer, MD
- Email: michael.sommer@medunigraz.at
- Phone: 004331638531033
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Vascular changes after endophthalmitis
We will see if multimodal eye imaging can reveal blood-vessel changes in adults who have had endophthalmitis.
-
Improving diagnosis of complex eye infections
This study is testing new methods to improve how doctors diagnose complicated eye infections, like endophthalmitis and corneal abscesses, to see if they can better identify the germs causing these problems.
-
Bioresorbable Magnesium Screws for Ankle Syndesmotic Injuries: A First Look
This pilot study tests whether a bioresorbable magnesium screw can safely fix ankle syndesmotic injuries in adults with isolated injuries or small fracture patterns.
-
Agreement between non-invasive cuff and arterial line BP during anesthesia induction
This study tests whether blood pressure readings from an automated upper-arm cuff align with continuous arterial line measurements in high-risk patients starting general anesthesia.
-
Point-of-Care Test for Early Infection Signs in Preterm Babies
This pilot observational study will see if a rapid point-of-care blood test can help detect early signs of infection in preterm infants and compare its results with standard lab tests.
-
Continuous body-temperature monitoring of preterm babies after birth using a wireless adhesive thermometer
This study tests whether a wireless, adhesive thermometer can continuously monitor temperature in preterm neonates during the first 15 minutes after birth.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.